Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: Results of a prospective study

Liver Transplantation

Volumn 9, Issue 8, 2003, Pages 822-826

  Testa, Giuliano ^a,b   Malagó, Massimo ^a   Nadalin, Silvio ^a   Treptow, Boris ^a   Paul, Andreas ^a   Frilling, Andrea ^a   Broelsch, Christoph E ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN; HEPARIN; HTK SOLUTION; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTACYCLIN; STEROID; UNIVERSITY OF WISCONSIN SOLUTION; URSODEOXYCHOLIC ACID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATIC ARTERY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FAILURE; LIVER GRAFT; LIVER PERFUSION; LIVER PRESERVATION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; REPERFUSION; SAFETY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0042062510     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50168     Document Type: Article

References (20)

1. Belzer FO, D'Alessandro AM, Hoffmann RM, Knechtle SJ, Reed A, Pirsch JD, et al. The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg 1992;215:579-583.
2. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980;28:295-302.
3. Upadhya GA, Strasberg SM. Glutathione, lactobionate, and histidine: Cryptic inhibitors of matrix metalloproteinase contained in University of Wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions. Hepatology 2000;31:1115-1122.
4. Hatano E, Kiuchi T, Tanaka A, Shinohara H, Kitai T, Satoh S, et al. Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation. Clin Sci (Colch) 1997;93:81-88.
5. Lange R, Erhard J, Rauen U, de Groot H, Eigler FW. Hepatocellular injury during preservation of human livers with UW and HTK solution. Transplant Proc 1997;29:400-402.
6. Pirenne J, Van Gelder F, Coosemans W, Aerts R, Gunson B, Koshiba T, et al. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation. Liver Transpl 2001;7:540-545.
7. Broelsch CE, Whitington PF, Emond JC, Heffron TG, Thistlethwaite JR, Stevens L, et al. Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg 1991;214:428-437.
8. Kiuchi T, Inomata Y, Uemoto S, Asonuma K, Egawa H, Hayashi M, et al. Living-donor liver transplantation in Kyoto, 1997. Clin Transpl 1997;191-198.
9. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999;67:321-327.
10. Marcos A. Right-lobe living donor liver transplantation. Liver Transpl 2000;6:S59-63.
11. Broelsch CE, Malago M, Testa G, Valentin Gamazo C. Living donor liver transplantation in adults: Outcome in Europe. Liver. Transpl 2000;6(suppl 2):S64-65.
12. Todo S, Furukawa H, Jin MB, Shimamura T. Living donor liver transplantation in adults: Outcome in Japan. Liver Transpl 2000;6:S66-72.
13. Kalayoglu M, Hoffmann RM, D'Alessandro AM, Pirsch JD, Sollinger HW, Belzer FO. Results of extended preservation of the liver for clinical transplantation. Transplant Proc 1989;21: 3487-3488.
14. Olthoff KM, Millis JM, Imagawa DK, Nuesse BJ, Derus LJ, Rosenthal JT, et al. Comparison of UW solution and Euro-Collins solutions for cold preservation of human liver grafts. Transplantation 1990;49:284-290.
15. Gubernatis G, Dietl KH, Kemnitz J, Oldhafer K, Hauss J, Buchholz B, et al. Extended cold preservation time (20 hours 20 minutes) of a human liver graft by using cardioplegic HTK solution. Transplant Proc 1991;23:2408-2409.
16. Holscher M, Groenewoud AF. Current status of the HTK solution of Bretschneider in organ preservation. Transplant Proc 1991;23:2334-2337.
17. van Gulik TM, Nio CR, Cortissos E, Klopper PJ, van der Heyde MN. Comparison of HTK solution and UW solution in 24- and 48-hour preservation of canine hepatic allografts. Transplant Proc 1993;25:2554.
18. Lange R, Erhard J, Rauen U, Hellinger A, de Groot H, Eigler FW. Injury to hepatocytes and non-parenchymal cells during the preservation of human livers with UW or HTK solution: A determination of hepatocellular enzymes in the effluent perfusate for preoperative evaluation of the transplant quality. Transpl Int 1996;9(suppl 1):S472-476.
19. Walcher F, Marzi I, Buhren V. Liver preservation in UW and HTK solution: The influence on sinusoidal perfusion after liver transplantation. Transplant Proc 1991;23:2376-2377.
20. Pomfret EA, Pomposelli JJ, Lewis WD, Gordon ED, Burns DL, Lally A, et al. Live donor adult liver transplantation using right lobe grafts: Donor evaluation and surgical outcome. Arch Surg 2001;136:425-433.